{
  "name": "Dementia",
  "remarks": [
    "right now this is just Alzheimer's but there are other dementias that could be adapted into this model"
  ],
  "states": {

    "Initial": {
      "type": "Initial",
      "distributed_transition": [
        {
          "distribution": 0.4,
          "transition": "AlzheimersGene"
        },
        {
          "distribution": 0.6,
          "transition": "Terminal"
        }
      ],
      "remarks": [
        "Alzheimer's has been shown to be significantly based on genetics, and there are specific genes to point to for early-onset:",
        "https://www.nia.nih.gov/alzheimers/publication/alzheimers-disease-genetics-fact-sheet",
        "Since Synthea does not currently model at the level of individual genes",
        "we'll use a simple probability to differentiate the population into who will and won't get alzheimers.",
        "The 40% chance does seem high, but the key factor here is the delay in when it appears.",
        "38% of people over age 85 have alzheimer's. ( http://www.alzheimers.net/resources/alzheimers-statistics/ )"
      ]
    },

    "AlzheimersGene": {
      "type": "Simple",
      "distributed_transition": [
        {
          "distribution": 0.95,
          "transition": "PreAlzheimers"
        },
        {
          "distribution": 0.05,
          "transition": "PreEarlyOnsetAlzheimers"
        }
      ],
      "remarks": [
        "Early onset Alzheimers affects roughly 5% of people with Alzheimer's. http://www.mayoclinic.org/diseases-conditions/alzheimers-disease/in-depth/alzheimers/art-20048356"
      ]
    },

    "PreAlzheimers": {
      "type": "Delay",
      "range": {
        "low": 64,
        "high": 80,
        "unit": "years"
      },
      "remarks": [
        "There is evidence that higher education leads to a delay in the onset of alzheimers."
      ],
      "conditional_transition": [
        {
          "condition": {
            "condition_type": "Socioeconomic Status",
            "category": "High"
          },
          "transition": "EducationDelay"
        },
        {
          "transition": "AlzheimersOnset"
        }
      ]
    },

    "EducationDelay": {
      "type": "Delay",
      "range": {
        "low": 5,
        "high": 10,
        "unit": "years"
      },
      "direct_transition": "AlzheimersOnset"
    },

    "AlzheimersOnset": {
      "type": "ConditionOnset",
      "target_encounter": "DiagnosisEncounter",
      "assign_to_attribute": "Type of Alzheimer's",
      "codes": [
        {
          "system": "SNOMED-CT",
          "code": "26929004",
          "display": "Alzheimer's disease (disorder)"
        }
      ],
      "direct_transition": "NoImpairment"
    },

    "PreEarlyOnsetAlzheimers": {
      "type": "Delay",
      "range": {
        "low": 40,
        "high": 64,
        "unit": "years"
      },
      "direct_transition": "EarlyOnsetAlzheimersOnset"
    },

    "EarlyOnsetAlzheimersOnset": {
      "type": "ConditionOnset",
      "target_encounter": "DiagnosisEncounter",
      "assign_to_attribute": "Type of Alzheimer's",
      "codes": [
        {
          "system": "SNOMED-CT",
          "code": "230265002",
          "display": "Familial Alzheimer's disease of early onset (disorder)"
        }
      ],
      "direct_transition": "NoImpairment"
    },

    "NoImpairment": {
      "type": "Delay",
      "range": {
        "low": 12,
        "high": 36,
        "unit": "months"
      },
      "remarks": [
        "1. Normal"
      ],
      "direct_transition": "VeryMildDecline"
    },

    "VeryMildDecline": {
      "type": "Delay",
      "range": {
        "low": 12,
        "high": 36,
        "unit": "months"
      },
      "remarks": [
        "2. Very mild decline, also considered normal aged forgetfulness"
      ],
      "direct_transition": "MildMemoryLoss"
    },

    "MildMemoryLoss": {
      "type": "Symptom",
      "symptom": "Memory Loss",
      "range": {
        "low": 1,
        "high": 50
      },
      "direct_transition": "MildDecline"
    },

    "MildDecline": {
      "type": "Delay",
      "range": {
        "low": 6,
        "high": 12,
        "unit": "months"
      },
      "remarks": [
        "3. Mild decline, aka mild cognitive impairment (MCI) progresses to the next stage in generally 2-4 years",
        "Persons at this stage display subtle deficits which are noted by others close to the subject",
        "https://www.alzinfo.org/understand-alzheimers/clinical-stages-of-alzheimers/"
      ],
      "conditional_transition": [
        {
          "condition": {
            "condition_type": "Symptom",
            "symptom": "Memory Loss",
            "operator": ">",
            "value": 40
          },
          "transition": "DiagnosisEncounter",
          "remarks": [
            "if the symptom is sufficiently noticeable enough people can be diagnosed in this stage, if not they will be diagnosed in the next stage"
          ]
        },
        {
          "condition": {
            "condition_type": "Symptom",
            "symptom": "Memory Loss",
            "operator": ">",
            "value": 30
          },
          "transition": "ModerateDecline"
        },
        {
          "transition": "MildMemoryLoss"
        }
      ]
    },

    "DiagnosisEncounter": {
      "type": "Encounter",
      "wellness": true,
      "remarks": [
        "This is the enounter where alzheimer's is diagnosed. ",
        "Typical life expectancy after an Alzheimer’s diagnosis is 4-to-8 years. (Alzheimer’s Association)"
      ],
      "direct_transition": "Diagnosis_MMSE_Score"
    },
    "Diagnosis_MMSE_Score": {
      "type": "Observation",
      "target_encounter": "DiagnosisEncounter",
      "range": {
        "low": 18,
        "high": 25
      },
      "remarks": [
        "The maximum MMSE score is 30 points. A score of 20 to 24 suggests mild dementia, ",
        "13 to 20 suggests moderate dementia, and less than 12 indicates severe dementia",
        "http://www.alz.org/alzheimers_disease_steps_to_diagnosis.asp",
        "also available is the Clinical Dementia Rating (CDR)",
        "http://alzheimer.wustl.edu/cdr/cdr.htm"
      ],
      "unit": "(score)",
      "codes": [
        {
          "system": "LOINC",
          "code": "72106-8",
          "display": "Total score [MMSE]"
        }
      ],
      "direct_transition": "Dementia_CarePlan"
    },

    "Dementia_CarePlan": {
      "type": "CarePlanStart",
      "target_encounter": "DiagnosisEncounter",
      "reason": "Type of Alzheimer's",
      "codes": [
        {
          "system": "SNOMED-CT",
          "code": "386257007",
          "display": "Demential management"
        }
      ],
      "activities": [
        {
          "system": "SNOMED-CT",
          "code": "850261000000100",
          "display": "Education about dementia"
        },
        {
          "system": "SNOMED-CT",
          "code": "710125008",
          "display": "Promotion of use of memeory skills"
        },
        {
          "system": "SNOMED-CT",
          "code": "315043002",
          "display": "Long term social support"
        }
      ],
      "direct_transition": "FirstPrescription"
    },

    "FirstPrescription": {
      "type": "Simple",
      "conditional_transition": [
        {
          "condition": {
            "condition_type": "Date",
            "operator": ">",
            "year": 2001
          },
          "transition": "FirstPrescription1",
          "remarks": [
            "galantamine(razadyne) fda approved in 2001"
          ]
        },
        {
          "condition": {
            "condition_type": "Date",
            "operator": ">",
            "year": 1996
          },
          "transition": "FirstPrescription2",
          "remarks": [
            "donepezil(aricept) fda approved in 1996"
          ]
        },
        {
          "condition": {
            "condition_type": "Date",
            "operator": ">",
            "year": 1993
          },
          "transition": "FirstPrescription3",
          "remarks": [
            "tarine first available in 1993"
          ]
        },
        {
          "transition": "ModerateDecline",
          "remarks": [
            "before 1993 there were no specific drugs approved for Alzheimer’s by the fda"
          ]
        }
      ]
    },

    "FirstPrescription1": {
      "type": "MedicationOrder",
      "target_encounter": "DiagnosisEncounter",
      "assign_to_attribute": "Alzheimer's Medication",
      "reason": "Type of Alzheimer's",
      "codes": [
        {
          "system": "RxNorm",
          "code": "602735",
          "display": "Galantamine 4 MG [Razadyne]"
        }
      ],
      "direct_transition": "ModerateDecline"
    },

    "FirstPrescription2": {
      "type": "MedicationOrder",
      "target_encounter": "DiagnosisEncounter",
      "assign_to_attribute": "Alzheimer's Medication",
      "reason": "Type of Alzheimer's",
      "codes": [
        {
          "system": "RxNorm",
          "code": "997221",
          "display": "Donepezil hydrochloride 10 MG [Aricept]"
        }
      ],
      "direct_transition": "ModerateDecline"
    },

    "FirstPrescription3": {
      "type": "MedicationOrder",
      "target_encounter": "DiagnosisEncounter",
      "assign_to_attribute": "Alzheimer's Medication",
      "reason": "Type of Alzheimer's",
      "codes": [
        {
          "system": "RxNorm",
          "code": "313185",
          "display": "Tacrine 10 MG Oral Capsule"
        }
      ],
      "direct_transition": "ModerateDecline"
    },

    "ModerateDecline": {
      "type": "Delay",
      "range": {
        "low": 5,
        "high": 7,
        "unit": "months"
      },
      "remarks": [
        "4. Moderate decline, or mild alzheimer's has a mean duration of 2 years.",
        "The diagnosis of alzheimer's can be made with considerable accuracy in this stage",
        "https://www.alzinfo.org/understand-alzheimers/clinical-stages-of-alzheimers/"
      ],
      "conditional_transition": [
        {
          "condition": {
            "condition_type": "Not",
            "condition": {
              "condition_type": "PriorState",
              "name": "DiagnosisEncounter"
            }
          },
          "transition": "DiagnosisEncounter"
        },
        {
          "condition": {
            "condition_type": "Symptom",
            "symptom": "Memory Loss",
            "operator": ">",
            "value": 70
          },
          "transition": "ModeratelySevere_Encounter"
        },
        {
          "transition": "ModerateMemoryLoss"
        }
      ]
    },

    "ModerateMemoryLoss": {
      "type": "Symptom",
      "symptom": "Memory Loss",
      "range": {
        "low": 40,
        "high": 80
      },
      "remarks": [
        "These numbers do not map to any real data, they are just picked mathematically to get the %s right"
      ],
      "direct_transition": "ModerateDecline"
    },

    "ModeratelySevere_Encounter": {
      "type": "Encounter",
      "encounter_class": "ambulatory",
      "reason": "Type of Alzheimer's",
      "codes": [
        {
          "system": "SNOMED-CT",
          "code": "316744009",
          "display": "Office Visit"
        }
      ],
      "direct_transition": "ModeratelySevere_MMSE_Score"
    },

    "ModeratelySevere_MMSE_Score": {
      "type": "Observation",
      "target_encounter": "ModeratelySevere_Encounter",
      "codes": [
        {
          "system": "LOINC",
          "code": "72106-8",
          "display": "Total score [MMSE]"
        }
      ],
      "range": {
        "low": 12,
        "high": 18
      },
      "remarks": [
        "The maximum MMSE score is 30 points. A score of 20 to 24 suggests mild dementia, ",
        "13 to 20 suggests moderate dementia, and less than 12 indicates severe dementia",
        "http://www.alz.org/alzheimers_disease_steps_to_diagnosis.asp"
      ],
      "unit": "(score)",
      "conditional_transition": [
        {
          "condition": {
            "condition_type": "Attribute",
            "attribute": "Alzheimer’s Medication",
            "operator": "is not nil"
          },
          "transition": "EndFirstPrescription"
        },
        {
          "transition": "SecondPrescription"
        }
      ]
    },

    "EndFirstPrescription": {
      "type": "MedicationEnd",
      "referenced_by_attribute": "Alzheimer's Medication",
      "direct_transition": "SecondPrescription"
    },

    "SecondPrescription": {
      "type": "Simple",
      "conditional_transition": [
        {
          "condition": {
            "condition_type": "Date",
            "operator": ">",
            "year": 2014
          },
          "transition": "SecondPrescription1",
          "remarks": [
            "memantine+donepezil(namzaric) fda approved in 2014"
          ]
        },
        {
          "condition": {
            "condition_type": "Date",
            "operator": ">",
            "year": 2003
          },
          "transition": "SecondPrescription2",
          "remarks": [
            "memantine(namenda) fda approved in 2003"
          ]
        },
        {
          "condition": {
            "condition_type": "Date",
            "operator": ">",
            "year": 1996
          },
          "transition": "SecondPrescription3",
          "remarks": [
            "donepezil(aricept) fda approved in 1996"
          ]
        },
        {
          "transition": "ModeratelySevereDecline"
        }
      ]
    },

    "SecondPrescription1": {
      "type": "MedicationOrder",
      "target_encounter": "ModeratelySevere_Encounter",
      "reason": "Type of Alzheimer's",
      "codes": [
        {
          "system": "RxNorm",
          "code": "1602593",
          "display": "Donepezil hydrochloride 10 MG / Memantine hydrochloride 28 MG [Namzaric]"
        }
      ],
      "direct_transition": "ModeratelySevereDecline"
    },

    "SecondPrescription2": {
      "type": "MedicationOrder",
      "target_encounter": "ModeratelySevere_Encounter",
      "reason": "Type of Alzheimer's",
      "codes": [
        {
          "system": "RxNorm",
          "code": "996741",
          "display": "Memantine hydrochloride 2 MG/ML [Namenda]"
        }
      ],
      "direct_transition": "ModeratelySevereDecline"
    },

    "SecondPrescription3": {
      "type": "MedicationOrder",
      "target_encounter": "ModeratelySevere_Encounter",
      "reason": "Type of Alzheimer's",
      "codes": [
        {
          "system": "RxNorm",
          "code": "998582",
          "display": "Donepezil hydrochloride 23 MG [Aricept]"
        }
      ],
      "direct_transition": "ModeratelySevereDecline"
    },

    "ModeratelySevereDecline": {
      "type": "Delay",
      "range": {
        "low": 12,
        "high": 24,
        "unit": "months"
      },
      "remarks": [
        "5. Moderately severe decline, aka mid-stage or moderate alzheimer's has a mean duration about 1.5 yrs",
        "https://www.alzinfo.org/understand-alzheimers/clinical-stages-of-alzheimers/"
      ],
      "direct_transition": "Severe_Encounter"
    },

    "Severe_Encounter": {
      "type": "Encounter",
      "encounter_class": "ambulatory",
      "reason": "Type of Alzheimer's",
      "codes": [
        {
          "system": "SNOMED-CT",
          "code": "316744009",
          "display": "Office Visit"
        }
      ],
      "direct_transition": "Severe_MMSE_Score"
    },

    "Severe_MMSE_Score": {
      "type": "Observation",
      "target_encounter": "Severe_Encounter",
      "codes": [
        {
          "system": "LOINC",
          "code": "72106-8",
          "display": "Total score [MMSE]"
        }
      ],
      "range": {
        "low": 6,
        "high": 12
      },
      "remarks": [
        "The maximum MMSE score is 30 points. A score of 20 to 24 suggests mild dementia, ",
        "13 to 20 suggests moderate dementia, and less than 12 indicates severe dementia",
        "http://www.alz.org/alzheimers_disease_steps_to_diagnosis.asp"
      ],
      "unit": "(score)",
      "direct_transition": "SevereDecline"
    },
    
    "SevereDecline": {
      "type": "Delay",
      "range": {
        "low": 20,
        "high": 40,
        "unit": "months"
      },
      "remarks": [
        "6. Severe decline, or moderately severe Alzheimer's contains 5 defined substages, the total duration approximately 2.5 yrs"
      ],
      "direct_transition": "VerySevere_Encounter"
    },

    "VerySevere_Encounter": {
      "type": "Encounter",
      "encounter_class": "ambulatory",
      "reason": "Type of Alzheimer's",
      "codes": [
        {
          "system": "SNOMED-CT",
          "code": "316744009",
          "display": "Office Visit"
        }
      ],
      "direct_transition": "VerySevere_MMSE_Score"
    },

    "VerySevere_MMSE_Score": {
      "type": "Observation",
      "target_encounter": "VerySevere_Encounter",
      "codes": [
        {
          "system": "LOINC",
          "code": "72106-8",
          "display": "Total score [MMSE]"
        }
      ],
      "range": {
        "low": 0,
        "high": 6
      },
      "remarks": [
        "The maximum MMSE score is 30 points. A score of 20 to 24 suggests mild dementia, ",
        "13 to 20 suggests moderate dementia, and less than 12 indicates severe dementia",
        "http://www.alz.org/alzheimers_disease_steps_to_diagnosis.asp"
      ],
      "unit": "(score)",
      "direct_transition": "VerySevereDecline"
    },

    "VerySevereDecline": {
      "type": "Delay",
      "range": {
        "low": 6,
        "high": 12,
        "unit": "months"
      },
      "remarks": [
        "7. Very severe decline, aka late-stage or severe alzheimer's contains 6 functional substages, each with a mean duration ~1 yr",
        "https://www.alzinfo.org/understand-alzheimers/clinical-stages-of-alzheimers/"
      ],
      "distributed_transition": [
        {
          "distribution": 0.16,
          "transition": "Pneumonia"
        },
        {
          "distribution": 0.16,
          "transition": "Death"
        },
        {
          "distribution": 0.68,
          "transition": "VerySevereDecline"
        }
      ]
    },

    "Pneumonia": {
      "type": "ConditionOnset",
      "target_encounter": "PneumoniaEncounter",
      "codes": [
        {
          "system": "SNOMED-CT",
          "code": "233604007",
          "display": "Pneumonia"
        }
      ],
      "remarks": [
        "Pneumonia is one of the most common causes of death among Alzheimer’s patients"
      ],
      "direct_transition": "PneumoniaEncounter"
    },

    "PneumoniaEncounter": {
      "type": "Encounter",
      "encounter_class": "inpatient",
      "reason": "Pneumonia",
      "codes": [
        {
          "system": "SNOMED-CT",
          "code": "34285007",
          "display": "Hospital admission"
        }
      ],
      "direct_transition": "PneumoniaDeath"
    },

    "PneumoniaDeath": {
      "type": "Death",
      "range": {
        "low": 4,
        "high": 14,
        "unit": "days"
      },
      "condition_onset": "Pneumonia",
      "direct_transition": "Terminal"
    },

    "Death": {
      "type": "Death",
      "referenced_by_attribute": "Type of Alzheimer's",
      "direct_transition": "Terminal"
    },

    "Terminal": {
      "type": "Terminal"
    }
  }
}
